Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of INNO-406 in adult
patients with imatinib-resistant or intolerant Philadelphia chromosome-positive (Ph+)
leukemias.